International Journal of Drug Policy
Volume 21, Issue 5 , Pages 429-431, September 2010

Older and sicker: Changing mortality of drug users in treatment in the North West of England

Centre for Public Health Research Directorate, Liverpool John Moores University, Castle House, North Street, Liverpool L3 2AY, United Kingdom

Received 16 November 2009; received in revised form 25 January 2010; accepted 26 January 2010. published online 22 February 2010.

Abstract 

Background

The study examines the age at which drug users die and ascertains whether there is a significant difference in the causes of death (‘drug related’ versus ‘non-drug related’) according to age.

Methods

Details of people reported to the North West of England's National Drug Treatment Monitoring System as dying (years 2003/2004–2007/2008) were matched by the Office for National Statistics to death notifications to identify the cause and date of death. Spearman's rank correlation was performed on median age at death by year. Mantel–Haenszel statistics tested the association between age and type of death, adjusted for year.

Results

Causes of death were ascertained for 504 people. Median age at death increased significantly from 36.46 in 2003/2004 to 41.38 in 2007/2008. The odds of a person aged 40 and over dying from a non-drug related death were 3.27 the odds of a person aged less than 40 dying from a non-drug related death.

Conclusion

Current focus on drug related deaths detracts attention from other causes; in particular, the types of death which disproportionately affect older drug users. Ongoing debates about reintegration into society and employment presuppose that drug users are of working age and are healthy enough to work.

Keywords: Drug use, Ageing, Mortality, Morbidity, Drug related death, Policy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(10)00013-7

doi:10.1016/j.drugpo.2010.01.012

International Journal of Drug Policy
Volume 21, Issue 5 , Pages 429-431, September 2010